Atomoxetine 40 mg Capsules Recalled for N-Nitroso Impurity Above Limits
Glenmark Pharmaceuticals is recalling 233,040 bottles of Atomoxetine 40 mg capsules nationwide due to N-Nitroso impurity above FDA safety limits. Patients should check their medication bottles and contact their healthcare provider.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: FDA Class II recall for N-Nitroso impurity exceeding safety limits. With no reported illnesses or injuries and the hazard being theoretical chemical contamination, this qualifies as a risk-of-harm product meriting a score of High (3) under the rubric.
Plain-English summary
Glenmark Pharmaceuticals Inc., USA is recalling 233,040 bottles of Atomoxetine 40 mg capsules. The medication was manufactured by Glenmark Pharmaceuticals Ltd. in Goa, India and distributed nationwide in the United States.
The recall was initiated due to the presence of N-Nitroso Atomoxetine impurity above FDA-recommended limits. This represents a Good Manufacturing Practice (CGMP) deviation identified by the manufacturer.
Affected lot numbers are: 19232540, 19232524, 19232553 (expiring May 2025); 19240510 (expiring January 2026); 19241489 (expiring March 2026); and 19243905, 19243935 (expiring September 2026). The product was distributed nationwide. Patients should verify the lot number and expiration date on their medication bottles and consult their healthcare provider for guidance regarding their current supply.
The recalled product
- Product
- ATOMOXETINE (ATOMOXETINE)
- Brand
- ATOMOXETINE
- Manufacturer
- Glenmark Pharmaceuticals Inc., USA
- Category
- Drug — Prescription Medication
- Hazard
- n-nitroso-impurity
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (11)
- Lot Numbers: 19232540
- 19232524
- 19232553
- Exp.: 5/2025
- 19240510
- Exp.: 1/2026
- 19241489
- Exp.: 3/2026
- 19243905
- 19243935
- Exp.: 9/2026.
UPCs (5)
- 0316714760018
- 0316714755014
- 0316714756011
- 0316714761015
- 0316714757018
Distribution
Distributed nationwide across the United States.
Related recalls
Same brand · ATOMOXETINE
- SevereAtomoxetine Capsules Recalled Due to Labeling Mix-Up Error
FDA (Drugs) · 2026-05-27
- HighAtomoxetine 80 mg Capsules Recalled for N-Nitroso Impurity Contamination
FDA (Drugs) · 2025-02-26
- HighAtomoxetine Capsules Recalled for N-Nitroso Impurity Above FDA Limits
FDA (Drugs) · 2025-02-26
- HighAtomoxetine Capsules Nationwide Recall for N-Nitroso Impurity Above FDA Limits
FDA (Drugs) · 2025-02-26
- HighAtomoxetine Capsules Recalled for Manufacturing Impurity Above Limits
FDA (Drugs) · 2025-02-26
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27
- LowPrimidone Tablets Recalled for Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27